Fluconazole Therapy for Cryptococcal Meningitis: Are Options Available Where It Is Needed Most—Africa?

被引：0
作者：
Tom M. Chiller
机构：
[1] Centers for Disease Control and Prevention,National Center for Emerging and Zoonotic Infectious Diseases
来源：
Current Fungal Infection Reports | 2010年 / 4卷 / 4期
关键词：
Fluconazole; Cryptococcal Meningitis; Primary Prophylaxis; Flucytosine; Preemptive Therapy;
D O I：
10.1007/s12281-010-0036-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：197 / 199
页数：2
相关论文
共 11 条
  • [1] Park BJ(2009)Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS AIDS 23 525-530
  • [2] Wannemuehler KA(2008)Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa AIDS 22 1897-1908
  • [3] Marston BA(2007)Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole Clin Infect Dis 45 76-80
  • [4] Lawn SD(2008)The impact of primary prophylaxis for cryptococcosis on fluconazole resistance in Candida species J Acquir Immune Defic Syndr 47 644-645
  • [5] Harries AD(undefined)undefined undefined undefined undefined-undefined
  • [6] Anglaret X(undefined)undefined undefined undefined undefined-undefined
  • [7] Bicanic T(undefined)undefined undefined undefined undefined-undefined
  • [8] Meintjes G(undefined)undefined undefined undefined undefined-undefined
  • [9] Wood R(undefined)undefined undefined undefined undefined-undefined
  • [10] Apisarnthanarak A(undefined)undefined undefined undefined undefined-undefined
12